Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk <i>NPM1</i>-mutated AMLOnyee Chan, Jeffrey E. Lancet, Caroline Hana et al.|Blood Advances|2024Cited by 31
The Prognostic Impact of <i>FLT3</i> in <i>NPM1</i>-Mutated AML: Co-Occurrence of <i>FLT3-ITD</i> and <i>FLT3-TKD</i> Confers Poor OutcomesOnyee Chan, David A. Sallman, Najla Al Ali et al.|Blood|2022Cited by 2
Secondary AML Mutations Confer Poor Prognosis in Patients with ELN Favorable Risk <i>NPM1</i>-Mutated AMLOnyee Chan, Jeffrey E. Lancet, Najla Al Ali et al.|Blood|2022Cited by 2